United Therapeutics Corporation

UTHR · Moat type: REGULIERUNG

MoatScore

10/10

Fair Value

894 USD

Margin of Safety

+40.5 %

Rating

STARK

United Therapeutics develops and markets therapies for rare and life-threatening diseases, particularly pulmonary arterial hypertension (PAH), and derives the vast majority of its revenues from patent-protected specialty pharmaceuticals with regulatory orphan drug protection.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.